SCHEMBL6472154

SCHEMBL6472154

CN(C)c1ccc(Cn2c(=O)c3cc(C(=O)O)sc3n(C)c2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
MMP13 P45452 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
TRPA1 O75762 5/20 0.38
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DCLK1 O15075 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
CHEK2 O96017 1/20 0.36
RET P07949 1/20 0.36
FER P16591 1/20 0.36
RPS6KB1 P23443 1/20 0.36
MAPK1 P28482 1/20 0.36
FLT4 P35916 1/20 0.36
FLT3 P36888 1/20 0.36
MAPK9 P45984 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6254110 0.87 TRPA1 (0.48) MEN1KMT2AMMP13SLC22A8TRPA1
SCHEMBL6728070 0.86 TRPA1 (0.46) MEN1KMT2AMAPTMMP13SLC22A8
SCHEMBL6916535 0.85 ALDH1A1 (0.47) MEN1KMT2AMAPTMMP13SLC22A8
SCHEMBL7038890 0.83 MMP13 (0.46) MAPTMMP13SLC22A8TRPA1SMN1; SMN2
SCHEMBL6703224 0.82 PTGS1 (0.41) MMP13SLC22A8TRPA1PKM
SCHEMBL6256637 0.80 KDM4E (0.38) MMP13SLC22A8PKMRAB9ASMN1; SMN2
SCHEMBL6235401 0.79 KDM4E (0.54) KMT2ATRPA1SMN1; SMN2MAPK1KDM4E
SCHEMBL7035440 0.78 KDM4E (0.40) MEN1KMT2AMAPTPKMSMN1; SMN2
SCHEMBL7021108 0.77 ALDH1A1 (0.41) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL6236545 0.77 MMP13 (0.44) MEN1KMT2AMAPTMMP13SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP disclosed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed